Litcius/Paper detail

Is it safe to administer neoadjuvant chemotherapy to patients undergoing hepatectomy for intrahepatic cholangiocarcinoma? ACS-NSQIP propensity-matched analysis

Woo Jin Choi, Tommy Ivanics, Marco P. A. W. Claasen, Steven Gallinger, Bettina E. Hansen, Gonzalo Sapisochín

2022HPB10 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePropensity score matchingHepatectomySurgeryNeoadjuvant therapyRetrospective cohort studyChemotherapyLogistic regressionIntrahepatic CholangiocarcinomaInternal medicineCancerBreast cancerResectionCholangiocarcinoma and Gallbladder Cancer StudiesGallbladder and Bile Duct DisordersHepatocellular Carcinoma Treatment and Prognosis
Is it safe to administer neoadjuvant chemotherapy to patients undergoing hepatectomy for intrahepatic cholangiocarcinoma? ACS-NSQIP propensity-matched analysis | Litcius